Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysis

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorABREU, Fernanda Gabriela de
dc.contributor.authorGOULART, Alessandra Carvalho
dc.contributor.authorBIRCK, Marina Gabriela
dc.contributor.authorBENSENOR, Isabela Martins
dc.date.accessioned2019-01-17T13:28:22Z
dc.date.available2019-01-17T13:28:22Z
dc.date.issued2018
dc.description.abstractBACKGROUND: Secondary prevention of stroke is a very important goal for achieving continuous reduction in stroke mortality rates over the next decades. DESIGN AND SETTING: Cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), with data from Salvador, Vitoria, Belo Horizonte, Rio de Janeiro, Sao Paulo and Porto Alegre. METHODS: This descriptive analysis focused on secondary prevention of stroke among participants who self-reported a medical diagnosis of stroke at the baseline of ELSA-Brasil, and its association with sociodemographic characteristics. RESULTS: Overall, 197 participants (13%) reported a prior medical history of stroke. Participants with stroke were older and less educated and had lower mean monthly family income, compared with nonstroke participants. Among all stroke cases, 23.7% did not use any medication for secondary prevention of stroke. Use of secondary prevention was higher among men than among women (respectively, 59.6% versus 40.4%; P = 0.02 for aspirin; and 71.4% versus 28.6%; P = 0.04 for other antiplatelet drugs). Having private health insurance was associated with greater use of less cost-effective and more expensive medications (like angiotensinogen receptor blockers) and a tendency to use antiplatelet drugs other than aspirin, among participants reporting stroke, compared with others. Use of medication decreased as time passed after suffering a stroke. CONCLUSIONS: In this sample of individuals with better access to healthcare services, use of secondary prevention for stroke was low, which may suggest that the situation in the general population is worse. Sex was the most important sociodemographic variable associated with low use of secondary prevention.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipBrazilian Ministry of Health (Science and Technology Department)
dc.description.sponsorshipBrazilian Ministry of Science and Technology
dc.description.sponsorshipCNPq National Research Council [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]
dc.description.sponsorshipCAPES
dc.description.sponsorshipCNPq
dc.identifier.citationSAO PAULO MEDICAL JOURNAL, v.136, n.5, p.398-406, 2018
dc.identifier.doi10.1590/1516-3180.2018.0129060818
dc.identifier.issn1516-3180
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29825
dc.language.isoeng
dc.publisherASSOCIACAO PAULISTA MEDICINAeng
dc.relation.ispartofSao Paulo Medical Journal
dc.rightsopenAccesseng
dc.rights.holderCopyright ASSOCIACAO PAULISTA MEDICINAeng
dc.subjectCerebrovascular disorderseng
dc.subjectStrokeeng
dc.subjectRisk factoreng
dc.subjectSecondary preventioneng
dc.subject.othercardiovascular-disease preventioneng
dc.subject.otherglobal burdeneng
dc.subject.otherhypertensioneng
dc.subject.otherawarenesseng
dc.subject.othermortalityeng
dc.subject.othertrendseng
dc.subject.otheravailabilityeng
dc.subject.otherprevalenceeng
dc.subject.othermanagementeng
dc.subject.otheradherenceeng
dc.subject.wosMedicine, General & Internaleng
dc.titleStroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysiseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus4
hcfmusp.contributor.author-fmusphcFERNANDA GABRIELA DE ABREU
hcfmusp.contributor.author-fmusphcALESSANDRA CARVALHO GOULART
hcfmusp.contributor.author-fmusphcMARINA GABRIELA BIRCK
hcfmusp.contributor.author-fmusphcISABELA JUDITH MARTINS BENSEñOR
hcfmusp.description.beginpage398
hcfmusp.description.endpage406
hcfmusp.description.issue5
hcfmusp.description.volume136
hcfmusp.origemWOS
hcfmusp.origem.pubmed30570091
hcfmusp.origem.scieloSCIELO:S1516-31802018000500398
hcfmusp.origem.scopus2-s2.0-85058897935
hcfmusp.origem.wosWOS:000454008600003
hcfmusp.publisher.citySAO PAULOeng
hcfmusp.publisher.countryBRAZILeng
hcfmusp.relation.referenceAQUINO EML, 1992, REV SAUDE PUBL, V26, P195, DOI 10.1590/S0034-89101992000300011eng
hcfmusp.relation.referenceAquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294eng
hcfmusp.relation.referenceBensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780eng
hcfmusp.relation.referenceBrasil. Ministerio da Saude Fundacao Oswaldo Cruz, 2005, PROGR FARM POP BRASeng
hcfmusp.relation.referenceBrasil. Ministerio da Saude. Secretaria de Ciencia Tecnologia e Insumos Estrategicos. Departamento de Assistencia Farmaceutica e Insumos Estrategicos., 2015, REL NAC MED ESS RENAeng
hcfmusp.relation.referenceCabral Norberto L, 2012, Am J Public Health, V102, pe90, DOI 10.2105/AJPH.2012.301024eng
hcfmusp.relation.referenceCarrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7eng
hcfmusp.relation.referenceChor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382eng
hcfmusp.relation.referenceDal Pizzol TD, 2010, CAD SAUDE PUBLICA, V26, P827, DOI 10.1590/S0102-311X2010000400024eng
hcfmusp.relation.referenceFasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481eng
hcfmusp.relation.referenceFeigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106eng
hcfmusp.relation.referenceFernandes TG, 2015, INT J STROKE, V10, P34, DOI 10.1111/ijs.12526eng
hcfmusp.relation.referenceGamboa CM, 2017, J AM HEART ASS, V6eng
hcfmusp.relation.referenceGuerra AA, 2004, REV PANAM SALUD PUBL, V15, P168, DOI 10.1590/S1020-49892004000300005eng
hcfmusp.relation.referenceGuo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026eng
hcfmusp.relation.referenceKernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024eng
hcfmusp.relation.referenceKim Yeon-Yong, 2017, J Prev Med Public Health, V50, P294, DOI 10.3961/jpmph.17.024eng
hcfmusp.relation.referenceKOUTIS A D, 1991, Scandinavian Journal of Primary Health Care, V9, P297, DOI 10.3109/02813439109018536eng
hcfmusp.relation.referenceLotufo PA, 2013, INT J STROKE, V8, P155, DOI 10.1111/j.1747-4949.2011.00757.xeng
hcfmusp.relation.referenceLotufo PA, 2009, INT J STROKE, V4, P40, DOI 10.1111/j.1747-4949.2009.00240.xeng
hcfmusp.relation.referenceLotufo Paulo Andrade, 2017, Rev. bras. epidemiol., V20, P129, DOI 10.1590/1980-5497201700050011eng
hcfmusp.relation.referenceLotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510eng
hcfmusp.relation.referenceMill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851eng
hcfmusp.relation.referenceMosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82eng
hcfmusp.relation.referencePicon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255eng
hcfmusp.relation.referenceSantos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004eng
hcfmusp.relation.referencePinto CDS, 2010, REV SAUDE PUBL, V44, P611, DOI 10.1590/s0034-89102010005000021eng
hcfmusp.relation.referenceSchmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027eng
hcfmusp.relation.referenceStoverinck MJM, 1996, J FAM PRACTICE, V43, P567eng
hcfmusp.relation.referenceVianna CA, 2012, CAD SAUDE PUBLICA, V28, P1122, DOI 10.1590/S0102-311X2012000600011eng
hcfmusp.relation.referenceWang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1eng
hcfmusp.relation.referenceYamauti SM, 2015, CAD SAUDE PUBLICA, V31, P1648, DOI 10.1590/0102-311X00054814eng
hcfmusp.relation.referenceBermudez JAZ, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.201605000SUPL2AP, 10.1590/s1518-8787.201605000supl2ap]eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationdcc95206-f5ea-4cc7-8c8f-f0d9b719c6b2
relation.isAuthorOfPublicationcd675f04-b4ad-47f1-8d3c-15f6cb73d8cf
relation.isAuthorOfPublication205a2baa-e3c3-4b34-8ffc-285263e04e10
relation.isAuthorOfPublication6911f59e-7ec9-4ad2-b746-580bf8b3d64d
relation.isAuthorOfPublication.latestForDiscoverydcc95206-f5ea-4cc7-8c8f-f0d9b719c6b2
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_ABREU_Stroke_at_baseline_of_the_Brazilian_Longitudinal_Study_2018.PDF
Tamanho:
183.61 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - LIM/51
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/10